Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Positive phase II results for Allox

July 13, 2004

Sumitomo discloses agents for fibrosis in patent literature

July 6, 2004

Novartis claims steryl sulfatase inhibitors with utility in acne therapy

June 30, 2004

NICE recommends use of Elidel for atopic eczema

June 30, 2004

Positive opinion for Raptiva for psoriasis in Europe

June 30, 2004

Sigma-Tau plans phase II European trial of TB4 for venous stasis ulcers

June 29, 2004

Liarozole receives U.S. orphan drug status for congenital ichthyosis

June 25, 2004

FDA sets action date for Metvix review

June 21, 2004

Novel IL-8 receptor antagonists and their use described by GSK

June 18, 2004

Synthetic Australian snake venom derivative effective for wound healing

June 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...